Industry Networking has an under-recognized skill gap. When you’re a strong networker, you can make deep connections and relationships that can change the trajectory of your business. If you struggle at it, which most do, your collected business cards are similar to junk mail.
Like a concierge service, the Canna Pac looks to ensure networking success.
This week we sit down with R.W. Navis to discuss the following:
Origin of The Canna Pac
How Canna Pac works
Difference between Executive Recruiting & Headhunting
How do you ensure you follow all the rules and regulations for compliance when you have never been inside the back of a dispensary or worked in the cannabis industry before?
In comes Dutchie.
Dutchie is an all-in-one technology platform powering the cannabis industry with Point of Sale, Ecommerce, Payments, and Insurance.
Their software that simplifies their operations, our customers can focus on what matters most—bringing the benefits of cannabis safely to consumers.
This week we sit down with Anne Fortkuza to discuss the following:
Online Cannabis Sales are doing massive numbers, and some companies don’t even have a functioning website.
With restricted tools for e-commerce because of cannabis-related challenges or unsure of the ROI for your digital store. Many companies need to take advantage of easy market share.
Positioning yourself to capture this market share and building your digital footprint is more accessible than most realize, and it starts by just understanding how it all works.
This week we sit down with Jeremy Johnson to discuss the following:
Why are certain states more ECOM focused?
How google search evolves as the Market matures
Understanding customers intent
Guest Links:
https://www.linkedin.com/in/jeremystephenjohnson/
https://www.dispenseapp.com/
Follow us: Our Links.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
Dr. Amanda Reiman conducted one of the first research studies on medical cannabis patients using cannabis as a substitute for alcohol and other drugs.
Surveying medical cannabis patients at the Berkeley Patient’s Group, her research reveals that many are using cannabis to help manage pain and mental health issues, often choosing it over alcohol, tobacco, and non-prescribed drugs. Her findings challenge conventional thinking and open up important conversations about substance use, addiction, and the potential role of cannabis in public health and policy.
This week we sit down with Dr. Amanda Reiman to discuss the following:
Cannabis as a hard reduction tool
Substitute Alcohol
THC tolerance break
Cannabis Risks
About Dr. Amanda Reiman
Amanda Reiman, PhD is the Chief Knowledge Officer for New Frontier Data, a data and insights company serving the legal cannabis industry. She has been studying cannabis use as it relates to human behavior and greater society for over twenty years.
Dr. Reiman earned her PhD in Social Welfare from the University of California and conducted one of the first research studies on medical cannabis patients and the use of cannabis as a substitute for alcohol and other drugs. An internationally recognized cannabis expert and public health researcher. Dr. Reiman has presented her research all over the world. She has written for/been quoted in The Huffington Post, New York Times, Washington Post, and Rolling Stone as well as numerous peer reviewed academic journals and several textbooks. She currently sits on the Board of the National Cannabis Roundtable and the Industrial Advisory Committee for Excelsior College’s Cannabis Program.
The Farm Bill in 2014 was the most sweeping reform in U.S. Cannabis history, and the langued that was renewed in 2018 is set to be renewed again this year. Are any changes on the horizon to be aware of?
As international markets continue to open, are these opportunities for expansion for U.S. operators, or will international operators be collecting the remnants of the U.S. cannabis operators?
This week we sit down with Global cannabis policy expert Bob Hoban to discuss the following:
Farm bill updates and how to prepare
International Updates with a focus on Germany
Merging of hemp and cannabis sectors
THC %
And so much more
About Bob Hoban:
Robert Hoban is a corporate and M&A attorney who sits at the center of the world’s largest commercial cannabis industry network. He is a leader of Clark Hill’s AmLaw-leading Cannabis Industry Group. As the cannabis industry commercialized, Bob has been widely credited for creating the class of lawyers now known as “cannabis attorneys.”
Guest Links:
https://www.clarkhill.com/people/robert-t-hoban/
https://www.linkedin.com/in/rhoban
Follow us: Our Links.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
In every other industry, there is a balance between the regulator and the regulated. This doesn’t exist In this controlled substance space. “I think the cannabis movement is a failure… the whole cannabis movement is fractured — businesses are one page, criminal justice [reformers] on another page.” Matt Zorn
This week we sit down with Matt Zorn to discuss the following:
How to Fix the Cannabis Industry, 280E
Rescheduling of Controlled Substances
How he’s pushing back on Government Red tape.
Aligning State and Federal Reform
About Matt Zorn:
He has significant expertise in federal jurisdiction and procedure. Matt is at home digging out case-changing evidence, crafting legal strategies under arcane statutes and procedures, eliciting critical deposition or trial testimony, and arguing on his feet to trial courts, appellate courts, and arbitrators.
Matt is also recognized as an authority on issues relating to the federal Controlled Substance Act and relating to cannabis regulation, even being named to the Law360 2020 Cannabis Editorial Advisory Board. Matt routinely speaks and publishes on issues relating to legal issues relating to controlled substances.
Matt has received national recognition for his work in IP and controlled substances litigation. The American Lawyer recently named Matt a finalist for Young Lawyer of the Year (Litigation), and the American Inns of Court named him a 2020 Pegasus Scholar. Best Lawyers in America named Matt “One to Watch,” and Thomson Reuters’ Super Lawyers recognized him as a “Texas Rising Star” in IP Litigation, Cannabis Law, and Administrative Law.
Before joining the firm, Matt was a judicial clerk to the Hon. Rodney Gilstrap, U.S. District Judge for the Eastern District of Texas, spending hundreds of hours in court helping manage one of the busiest trial dockets in the country. Before then he was a litigator with Paul, Weiss in New York City.
